90755-P1 05/24
LEGG MASON PARTNERS INVESTMENT TRUST
SUPPLEMENT DATED MAY 9, 2024
TO THE SUMMARY PROSPECTUS AND PROSPECTUS,
EACH DATED MARCH 1, 2024, OF
CLEARBRIDGE MID CAP GROWTH FUND (THE FUND)
I. | The following replaces the table in the section of the Funds Summary Prospectus and Prospectus titled Management Portfolio managers: |
Portfolio manager | Title | Portfolio manager of the fund since | ||
Brian M. Angerame | Managing Director and Portfolio Manager of ClearBridge | 2010 | ||
Jeffrey Bailin, CFA | Director and Portfolio Manager of ClearBridge | December 2023 | ||
Aram E. Green | Managing Director and Portfolio Manager of ClearBridge | 2010 | ||
Matthew Lilling, CFA | Director and Portfolio Manager of ClearBridge | 2020 |
II. | The following replaces the table in the section of the Funds Prospectus titled More on fund management Portfolio managers: |
Portfolio manager | Title and recent biography | Portfolio manager of the fund since | ||
Brian M. Angerame | Mr. Angerame is a Managing Director and Portfolio Manager of ClearBridge and has 29 years of industry experience. Mr. Angerame joined a predecessor to the subadviser in 2000. Mr. Angerame was formerly an equity research analyst at ClearBridge responsible for the consumer discretionary, consumer staples and industrials sectors. | 2010 | ||
Jeffrey Bailin, CFA | Mr. Bailin is a Director and Portfolio Manager of ClearBridge with 14 years of industry experience. Mr. Bailin joined ClearBridge in 2015. Prior to ClearBridge, he worked as Vice President & Lead Analyst, Equity Research for Health Care Distribution & Technology at Credit Suisse. | December 2023 | ||
Aram E. Green | Mr. Green is a Managing Director and Portfolio Manager of ClearBridge and has 22 years of industry experience. He was formerly an equity analyst at Hygrove Partners LLC. Mr. Green joined the subadviser in 2006. | 2010 | ||
Matthew Lilling, CFA | Mr. Lilling is a Director and Portfolio Manager of ClearBridge and has 17 years of industry experience. He joined ClearBridge in 2010. | 2020 |
Please retain this supplement for future reference.